{
  "meta": {
    "title": "5_Ans_Introduction_Parasympathomimetics",
    "url": "https://brainandscalpel.vercel.app/5-ans-introduction-parasympathomimetics-a8d54ebc.html",
    "scrapedAt": "2025-11-30T12:34:31.625Z"
  },
  "questions": [
    {
      "text": "What is the principal post-ganglionic neurotransmitter of the parasympathetic system?",
      "choices": [
        {
          "id": 1,
          "text": "Dopamine"
        },
        {
          "id": 2,
          "text": "Nor-epinephrine"
        },
        {
          "id": 3,
          "text": "Acetylcholine"
        },
        {
          "id": 4,
          "text": "GABA"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span>The principal&nbsp;<strong>post-ganglionic</strong> neurotransmitter of the <strong>parasympathetic</strong> system is&nbsp;<strong>acetylcholine.</strong></span></p><hr><h3>Related Pearl: Basics of autonomic nervous system</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Autonomic nervous system</strong></span></td>\n<td><span><strong>Para-sympathetic system</strong></span></td>\n<td><span><strong>Sympathetic system</strong></span></td>\n</tr>\n<tr>\n<td><span>Outflow</span></td>\n<td>\n<div><span>Cranio-sacral</span></div>\n<ul>\n<li>\n<div><span>Cranial nerve nuclei - III, VII, IX, X</span></div>\n</li>\n<li>\n<div><span>Sacral segments - S2 to S4</span></div>\n</li>\n</ul>\n</td>\n<td><span>Thoraco-lumbar</span>\n<ul>\n<li><span>T1 - L2</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Pre-ganglionic receptor</span></td>\n<td><span>N<sub>n</sub> (Nicotinic neuronal)</span></td>\n<td><span>N<sub>n</sub></span></td>\n</tr>\n<tr>\n<td>\n<p><span>Pre-ganglionic neurotransmitter&nbsp;</span><span>(from CNS)</span></p>\n</td>\n<td><span>Acetylcholine</span></td>\n<td><span>Acetylcholine</span></td>\n</tr>\n<tr>\n<td><span>Post-ganglionic receptors</span></td>\n<td><span>Muscarinic or Nicotinic</span></td>\n<td><span>Alpha or Beta</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-Ganglionic neurotransmitter&nbsp;</span><span>(to the organ)</span></p>\n</td>\n<td><span>Acetylcholine</span></td>\n<td><span>Nor-epinephrine</span><br /><span>Exceptions</span>\n<ul>\n<li><span>Renal system-Dopamine</span></li>\n<li><span>Sweat and adrenal glands - Acetylcholine</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Features</span></td>\n<td>\n<ul>\n<li><span>The ganglion is located closer to the effector organ</span></li>\n<li><span>Pre-ganglionic fibers are longer</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>The ganglion is located closer to the spinal cord</span></li>\n<li><span>Post-ganglionic fibers are longer</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><span>Note: The nerve roots arising from the CNS are all nicotinic cholinergic.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2507",
      "difficulty": "easy"
    },
    {
      "text": "While conducting animal studies, a scientist is experimenting with different properties of drugs acting on the ANS. He identifies a drug that inhibits the rate-limiting step in acetylcholine synthesis in nerve terminals. What is this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Choline"
        },
        {
          "id": 2,
          "text": "Hemicholinium"
        },
        {
          "id": 3,
          "text": "Acetylcholine esterase"
        },
        {
          "id": 4,
          "text": "Botulinium toxin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>rate-limiting step</strong> in acetylcholine synthesis is the <strong>active uptake</strong> of<strong> choline</strong> into the nerve terminal, which is <strong>inhibited</strong> by<strong> hemicholinum.</strong></p>\n<p>Option A: Choline is the precursor of acetylcholine and is taken up from the synaptic cleft into the nerve terminal.</p>\n<p>Option C: Acetylcholine esterase is involved in the breakdown of acetylcholine after it is released into the synaptic cleft.</p>\n<p>Option D: Botulinum toxin inhibits the release of acetylcholine from nerve terminals.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1c164d17405742588be93f8c5a097090x1280x2124.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2514",
      "difficulty": "medium"
    },
    {
      "text": "What is the drug that acts on SNARE?",
      "choices": [
        {
          "id": 1,
          "text": "Hemicholinum"
        },
        {
          "id": 2,
          "text": "Botulinum toxin"
        },
        {
          "id": 3,
          "text": "Hexamethonium"
        },
        {
          "id": 4,
          "text": "Acetylcholinesterase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The drug which acts on <strong>SNARE</strong> (Soluble N-ethylmalimide Sensitive Factor (NSF) Attachment protein Receptor) is <strong>botulinum toxin</strong>.</p>\n<p>SNARE proteins play a critical role in the fusion of the vesicle with the cell membrane and the exocytosis of the neurotransmitter from the pre-synaptic membrane. <strong>Inhibition</strong> of these <strong>SNARE</strong> proteins&nbsp;<strong>inhibits</strong> the<strong> release</strong> of<strong> acetylcholine</strong> from synaptic terminals.</p>\n<p>It is useful to treat spastic and neurological conditions associated with increased cholinergic activity like:</p>\n<ul>\n<li>Blepharospasm</li>\n<li>Spastic cerebral palsy</li>\n<li>Torticollis</li>\n<li>Chronic resistant migraine</li>\n</ul>\n<p>Option A: Hemicholinum inhibits the uptake of choline into nerve terminals.</p>\n<p>Option C: Hexamethonium is a ganglionic blocker.</p>\n<p>Option D: Acetylcholine esterase is involved in the breakdown of acetylcholine after it is released into the synaptic cleft.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2acfd56c030143abb12025c6fd80fcebx1280x2124.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2513",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements regarding acetylcholine is incorrect ?",
      "choices": [
        {
          "id": 1,
          "text": "It has no systemic therapeutic use"
        },
        {
          "id": 2,
          "text": "It is metabolised by both acetylcholine esterase and butyrylcholine esterase"
        },
        {
          "id": 3,
          "text": "It is used topically during ophthalmic surgery"
        },
        {
          "id": 4,
          "text": "It has good CNS penetration"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Acetylcholine</strong>&nbsp;does not have a good CNS penetration as it&nbsp;is a <strong>quaternary ammonium compound</strong>.&nbsp;</p>\n<p>Neostigmine and glycopyrrolate are also quaternary ammonium compounds and their entry into CNS is limited.&nbsp;<strong>Tertiary ammonium compounds</strong> like physostigmine have <strong>good CNS penetration.&nbsp;</strong></p>\n<p>Options A and B: Acetylcholine has virtually no systemic use because of its diffuse action and rapid hydrolysis by both acetylcholine esterase and plasma butyrylcholine esterase.&nbsp;</p>\n<p>Option C: Acetylcholine is used during ophthalmic surgery for producing rapid miosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4726",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following causes an increase in ACh release from the presynaptic neuron?",
      "choices": [
        {
          "id": 1,
          "text": "Potassium channel blocker"
        },
        {
          "id": 2,
          "text": "Sodium channel blocker"
        },
        {
          "id": 3,
          "text": "Calcium channel blocker"
        },
        {
          "id": 4,
          "text": "Chlorine channel blocker"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Potassium channel blockers</strong> cause an <strong>increase</strong> in <strong>ACh release</strong> from the <strong>presynaptic</strong> neuron.</p>\n<p>Presynaptic potassium channel block promotes the activation of voltage-gated calcium channels. This leads to a release of acetylcholine in the neuromuscular junction.</p>\n<p>Aminopyridines (K+ channel blockers) are used in the treatment of Lambert-Eaton myasthenic syndrome which helps to improve muscle strength.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0133",
      "difficulty": "medium"
    },
    {
      "text": "You notice your senior performing a vagal maneuver in a stable patient with PSVT. Which of the following muscarinic receptors mediate the therapeutic effect of this maneuver?",
      "choices": [
        {
          "id": 1,
          "text": "M1"
        },
        {
          "id": 2,
          "text": "M2"
        },
        {
          "id": 3,
          "text": "M3"
        },
        {
          "id": 4,
          "text": "M4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In vagal maneuver, the <strong>parasympathetic</strong> nervous system mediates activity on the <strong>heart</strong> via the <strong>M2 muscarinic receptor</strong> (most predominant subtype).</p>\n<p>The receptors in the autonomic nervous system (ANS) are of 2 types:</p>\n<ul>\n<li>Muscarinic:\n<ul>\n<li>5 Subtypes - M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, M<sub>4</sub>, M<sub>5</sub></li>\n<li>M<sub>1</sub>, M<sub>3</sub>, M<sub>5</sub>&nbsp;are&nbsp;G<sub>q</sub> coupled receptors</li>\n<li>M<sub>2</sub>, M<sub>4&nbsp;</sub>are&nbsp;G<sub>i</sub>/G<sub>o&nbsp;</sub>coupled receptors</li>\n</ul>\n</li>\n<li>Nicotinic:\n<ul>\n<li>2 Subtypes - N<sub>m&nbsp;</sub>(Neuromuscular junction), N<sub>n&nbsp;</sub>(CNS, Ganglion, Adrenal glands)</li>\n<li>Nicotinic receptors are ion channels</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Receptors of Parasympathetic system</td>\n<td>Subtype</td>\n<td>Site</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Nicotinic</td>\n<td>N<sub>m</sub></td>\n<td>Neuromuscular junction</td>\n</tr>\n<tr>\n<td>N<sub>n</sub></td>\n<td>CNS, ganglia, Adrenal gland</td>\n</tr>\n<tr>\n<td rowspan=\"5\">Muscarinic</td>\n<td>M<sub>1</sub></td>\n<td>CNS, Ganglia, Salivary, and gastric glands</td>\n</tr>\n<tr>\n<td><strong>M<sub>2</sub></strong></td>\n<td><strong>Heart</strong></td>\n</tr>\n<tr>\n<td>M<sub>3</sub></td>\n<td>Smooth muscles, secretory glands, eyes - pupils, and blood vessels</td>\n</tr>\n<tr>\n<td>M<sub>4</sub></td>\n<td>CNS</td>\n</tr>\n<tr>\n<td>M<sub>5</sub></td>\n<td>CNS</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2516",
      "difficulty": "easy"
    },
    {
      "text": "What is the mechanism by which acetylcholine causes a decrease in the heart rate?",
      "choices": [
        {
          "id": 1,
          "text": "Delayed diastolic depolarization"
        },
        {
          "id": 2,
          "text": "Increase in plateau"
        },
        {
          "id": 3,
          "text": "Decrease in preload"
        },
        {
          "id": 4,
          "text": "Increase in afterload"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The mechanism by which <strong>acetylcholine</strong> causes a decrease in the heart rate is by <strong>decreasing</strong> the <strong>diastolic depolarization.</strong></p>\n<p>The acetylcholine released from the vagal nerve acts on the <strong>M2 receptor</strong> (&beta;&gamma; subunit of G protein) on the <strong>SA node</strong>. This opens a special set of potassium channels causing an efflux of potassium (I<sub>KAch</sub>)&nbsp;which hyperpolarizes the SA node (I<sub>h</sub>). The resultant current (I<sub>h</sub>) slows the diastolic depolarization thereby causing bradycardia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7023",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old woman who was diagnosed with Sjogren's syndrome is on treatment with cevimeline. On which receptor does this drug mainly act for the expulsion of secretions from the salivary gland?",
      "choices": [
        {
          "id": 1,
          "text": "M1"
        },
        {
          "id": 2,
          "text": "M2"
        },
        {
          "id": 3,
          "text": "M3"
        },
        {
          "id": 4,
          "text": "M4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cevimeline</strong> is an&nbsp;<strong>M3 receptor agonist</strong> resulting in the <strong>expulsion</strong> of the secretions from the salivary gland.&nbsp;This drug also enhances expulsion of lacrimal secretions in&nbsp;<strong>Sj&ouml;gren&rsquo;s syndrome</strong>.</p>\n<p>Both M1 and M3 receptors are present in a salivary gland. Activation of&nbsp;<strong>M1</strong>&nbsp;<strong>increases</strong><strong>&nbsp;secretion </strong>and&nbsp;<strong>M3</strong>&nbsp;causes<strong>&nbsp;smooth muscle contraction</strong>&nbsp;and <strong>expulsion</strong> of the secretions.</p>\n<table>\n<tbody>\n<tr>\n<td>Receptors of Parasympathetic system</td>\n<td>Subtype</td>\n<td>Site</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Nicotinic</td>\n<td>N<sub>m</sub></td>\n<td>Neuromuscular junction</td>\n</tr>\n<tr>\n<td>N<sub>n</sub></td>\n<td>CNS, ganglia, Adrenal gland</td>\n</tr>\n<tr>\n<td rowspan=\"5\">Muscarinic</td>\n<td>M<sub>1</sub></td>\n<td>CNS, Ganglia, Salivary, and gastric glands</td>\n</tr>\n<tr>\n<td>M<sub>2</sub></td>\n<td>Heart</td>\n</tr>\n<tr>\n<td><strong>M<sub>3</sub></strong></td>\n<td>Smooth muscles, <strong>secretory glands</strong>, eyes - pupils, and blood vessels</td>\n</tr>\n<tr>\n<td>M<sub>4</sub></td>\n<td>CNS</td>\n</tr>\n<tr>\n<td>M<sub>5</sub></td>\n<td>CNS</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2519",
      "difficulty": "easy"
    },
    {
      "text": "You are asked to prescribe a cholinergic agent to a patient suffering from Alzheimer's disease. Which of the following drugs cannot be chosen?",
      "choices": [
        {
          "id": 1,
          "text": "Galantamine"
        },
        {
          "id": 2,
          "text": "Donepezil"
        },
        {
          "id": 3,
          "text": "Tacrine"
        },
        {
          "id": 4,
          "text": "Memantine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Memantine</strong> is an <strong>NMDA receptor antagonist </strong>(not a cholinergic agent) indicated for the management of moderate to severe<strong> Alzheimer’s disease.</strong></p>\n<p>Donepezil, galantamine, and tacrine are centrally acting cholinesterase inhibitors indicated for Alzheimer’s disease.<br /><br />Note: In this scenario, you are asked to prescribe a <strong>cholinergic</strong> drug. <strong>Tacrine</strong>, a cholinergic drug, although hepatotoxic, is still <strong>approved for use</strong> in Alzheimer's disease. Hence, <strong>memantine</strong> is the best answer.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2526",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following conditions should cholinomimetic drugs be avoided?",
      "choices": [
        {
          "id": 1,
          "text": "Closed angle glaucoma"
        },
        {
          "id": 2,
          "text": "Bradycardia"
        },
        {
          "id": 3,
          "text": "Cobra bite"
        },
        {
          "id": 4,
          "text": "Myasthenia gravis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cholinomimetics</strong> cannot be used in bradycardia.<strong>&nbsp;</strong>They&nbsp;<strong>cause&nbsp;bradycardia</strong> by its action on M2 receptors on the heart.</p>\n<p>In bradycardia, an anticholinergic agent like <strong>atropine</strong> is <strong>indicated.</strong></p>\n<p>Option A - Cholinomimetics like pilocarpine are used in both open-angle and closed-angle glaucoma<strong>.</strong></p>\n<p>Option C - Cobra venom contains a curare-like neurotoxin. Although antivenom is the specific antidote, symptoms can be controlled by a combination of neostigmine and atropine.</p>\n<p>Option D - Cholinesterase inhibitors like neostigmine and pyridostigmine are indicated in myasthenia gravis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2520",
      "difficulty": "easy"
    },
    {
      "text": "Neostigmine is administered to a post-op patient to reverse neuromuscular blockade. What is its mechanism of action?",
      "choices": [
        {
          "id": 1,
          "text": "It blocks the action of acetylcholine"
        },
        {
          "id": 2,
          "text": "It interferes with the action of choline transferase"
        },
        {
          "id": 3,
          "text": "It interferes with the action of choline acetyl transferase"
        },
        {
          "id": 4,
          "text": "It interferes with the action of acetylcholine esterase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Muscle weakness is improved by <strong>neostigmine</strong> as it <strong>interferes</strong> with the action of <strong>acetylcholine esterase.</strong></p>\n<p>Neostigmine is a&nbsp;<strong>cholinesterase inhibitor</strong>&nbsp;used mainly to improve muscle tone in people with myasthenia gravis, and also to reverse the effects of non-depolarizing muscle relaxants such as rocuronium and vecuronium at the end of an operation.&nbsp;</p>\n<p>Inhibition of acetylcholine esterase <strong>increases</strong> the <strong>acetylcholine</strong> levels in the <strong>synapse</strong> that can act on receptors over the large surface area and for longer periods of time, reducing the weakness.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/17de91627d8047d984a749fcc6eac33fx1280x2234.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2525",
      "difficulty": "easy"
    },
    {
      "text": "A first-year anesthesia resident administered neostigmine to a patient who was accidentally given a slightly excessive bolus dose of suxamethonium. What is the most probable effect this is likely to produce?",
      "choices": [
        {
          "id": 1,
          "text": "Complete reversal"
        },
        {
          "id": 2,
          "text": "Incomplete reversal"
        },
        {
          "id": 3,
          "text": "No effect"
        },
        {
          "id": 4,
          "text": "Enhanced relaxation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Neostigmine <strong>prolongs the muscle relaxation</strong>&nbsp;caused by suxamethonium (succinylcholine) instead of reversing the block.</p>\n<p>The contraction of a muscle is achieved by a cycle of ACh binding and its degradation.&nbsp;<strong>Depolarising</strong> <strong>neuromuscular blockers</strong>&nbsp; (such as suxamethonium) acts by binding to the receptors much longer than ACh and causing a&nbsp;<strong>prolonged depolarization,</strong>&nbsp;resulting in an eventual&nbsp;blocking of neuromuscular transmission and<strong>&nbsp;flaccid paralysis.&nbsp;</strong></p>\n<p>AChE metabolizes ACh and plasma cholinesterase metabolizes suxamethonium (SCh). <strong>Neostigmine</strong> blocks <strong>both enzymes</strong>. By inhibiting AChE, neostigmine increases the ACh concentration in the synaptic cleft. But this cannot reverse the block as the depolarized nerves are unresponsive to any stimuli during this period. However, the simultaneous <strong>inhibition of plasma cholinesterase</strong> decreases the degradation of SCh&nbsp;and therefore <strong>potentiates the neuromuscular block</strong> of suxamethonium, resulting in prolonged muscle relaxation.</p>\n<p>Neostigmine can be used only as a <strong>reversal</strong> agent for&nbsp;neuromuscular blockade caused by competitive <strong>non-depolarising</strong> blockers such as <strong>vecuronium.</strong>&nbsp;</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b9ffc23f906f4e298f36f21819ea8f70x1280x2234.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4723",
      "difficulty": "hard"
    },
    {
      "text": "A 45-year-old woman presented to the medicine OPD with complaints of muscle weakness and blurring of vision following exertion. On examination, the patient had ptosis. What is the drug that can be used in the diagnosis of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Physostigmine"
        },
        {
          "id": 2,
          "text": "Edrophonium"
        },
        {
          "id": 3,
          "text": "Neostigmine"
        },
        {
          "id": 4,
          "text": "Pyridostigmine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Edrophonium</strong>, a <strong>short-acting</strong> anticholinesterase agent is used for diagnosing <strong>myasthenia gravis. </strong>It is also called the<strong>&nbsp;tensilon test.</strong></p>\n<p>Initially, 2 mg is administered. If improvements of symptoms do not occur within 45 seconds, an additional 8 mg can be administered.&nbsp;<strong>Improvement of strength</strong> unaccompanied by lingual fasciculations (generally present in non-myasthenics) is a <strong>positive test</strong>.</p>\n<p>Edrophonium is short-acting because:</p>\n<ul>\n<li>The binding site of edrophonium to acetylcholine esterase - choline subsite of the active center</li>\n<li>No reaction with the enzyme - reversible binding only</li>\n<li>Quaternary structure - rapid elimination</li>\n</ul>\n<p>Note: An excessive dose of anti-cholinesterase drugs results in a cholinergic crisis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2528",
      "difficulty": "easy"
    },
    {
      "text": "What is the drug used to differentiate myasthenia gravis from cholinergic crisis?",
      "choices": [
        {
          "id": 1,
          "text": "Obidoxime"
        },
        {
          "id": 2,
          "text": "Edrophonium"
        },
        {
          "id": 3,
          "text": "Donepezil"
        },
        {
          "id": 4,
          "text": "Atropine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The drug used to differentiate myasthenia gravis from a cholinergic crisis is <strong>edrophonium.</strong></p>\n<p>Muscle weakness is a common presentation in patients with myasthenia gravis and cholinergic crisis (excessive dose of anti-ChE drugs).&nbsp;Intravenous injection of edrophonium&nbsp;<strong>improves muscular weakness</strong> in a patient with <strong>myasthenia gravis</strong> and not in a case of cholinergic crisis.&nbsp;</p>\n<p>The test used for this differentiation is known as the <strong>edrophonium test.&nbsp;</strong></p>\n<p>Initially, 2 mg is administered; if improvements of symptoms do not occur within 45 seconds, an additional 8 mg can be administered.&nbsp;Improvement of strength is a positive test for myasthenia gravis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7567",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs would you use in the treatment of a patient with myasthenia gravis?",
      "choices": [
        {
          "id": 1,
          "text": "d-Tubocurarine"
        },
        {
          "id": 2,
          "text": "Hexamethonium"
        },
        {
          "id": 3,
          "text": "Ambenonium"
        },
        {
          "id": 4,
          "text": "Gallamine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Ambenonium, </strong>pyridostigmine, and neostigmine&nbsp;are<strong>&nbsp;</strong>the anti-cholinesterase drugs&nbsp;<strong>indicated</strong> in the treatment of<strong> myasthenia gravis.</strong></p>\n<p>Neostigmine and its congeners can improve muscle contractions by allowing released acetylcholine to accumulate and act on the receptors over a large area. They also have an additional direct depolarizing effect on the motor endplate.</p>\n<p>Options A and D: d-Tubocurarine and gallamine are non-depolarising neuromuscular blockers and can exacerbate myasthenia.</p>\n<p>Option B: Hexamethonium is a ganglionic blocker and not indicated for myasthenia gravis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2529",
      "difficulty": "hard"
    },
    {
      "text": "A patient presents to the emergency department with diarrhea, sweating, excessive lacrimation, and salivation. His pulse rate is 55/min and his plasma cholinesterase level was 50U/mL. Which of the following can be used to treat this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Neostigmine"
        },
        {
          "id": 2,
          "text": "Atropine"
        },
        {
          "id": 3,
          "text": "Epinephrine"
        },
        {
          "id": 4,
          "text": "Benztropine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features are suggestive of <strong>organophosphate poisoning</strong> and <strong>IV atropine</strong> is the treatment of choice.</p>\n<p>The organophosphates commonly used as pesticides are anticholinesterases.&nbsp;Toxicity occurs by excessive inhalation of vapors, ingestion, or percutaneous absorption. It inhibits the cholinesterase activity which results in an increase of acetylcholine, leading to cholinergic symptoms.</p>\n<p>The predominant initial signs are of muscarinic excess which includes:&nbsp;<strong>(DUMBBELSS)</strong></p>\n<ul>\n<li><strong>D</strong>iarrhea</li>\n<li><strong>U</strong>rination</li>\n<li><strong>M</strong>iosis</li>\n<li><strong>B</strong>ronchospasm</li>\n<li><strong>B</strong>radycardia</li>\n<li><strong>E</strong>mesis</li>\n<li><strong>L</strong>acrimation</li>\n<li><strong>S</strong>alivation</li>\n<li><strong>S</strong>weating</li>\n</ul>\n<p>This may be followed by cognitive disturbances, convulsions, and neuromuscular blockade.</p>\n<p>Treatment:</p>\n<ul>\n<li>Maintenance of vital signs particularly respiration</li>\n<li>Removal of clothing and washing of the skin</li>\n<li><strong>IV atropine 2- 5 mg. </strong>If&nbsp;IV administration is&nbsp;not possible, then <strong>2 mg IM</strong>&nbsp;every 5-10 minutes (till muscarinic symptoms disappear)</li>\n<li><strong>Pralidoxime,</strong> a cholinesterase reactivator can also be used for treatment</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0129",
      "difficulty": "easy"
    },
    {
      "text": "What is the mechanism of action of atropine in the management of organophosphate poisoning?",
      "choices": [
        {
          "id": 1,
          "text": "Reactivates acetylcholineesterase"
        },
        {
          "id": 2,
          "text": "Competes with acetylcholine release"
        },
        {
          "id": 3,
          "text": "Binds with both nicotinic and muscarinic acetylcholine receptors"
        },
        {
          "id": 4,
          "text": "Is a competitive antagonist of acetylcholine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Atropine</strong> is useful in organophosphate poisoning because it is a <strong>competitive antagonist</strong> of<strong> acetylcholine.</strong>&nbsp;</p>\n<p>An acetylcholinesterase enzyme has an esteratic and an anionic site. The <strong>organophosphates</strong> bind to&nbsp;the esteratic (active) site of <strong>AChEs</strong> (acetylcholine esterases) and<strong>&nbsp;deactivate</strong>&nbsp;it.</p>\n<p>This results in excessive Ach causing increased&nbsp;muscarinic activity like increased tracheobronchial and salivary secretions, bronchoconstriction, miosis, bradycardia, and to a lesser extent peripheral ganglionic and CNS actions. It has relatively insignificant action on nicotinic receptors.&nbsp;</p>\n<p><strong>Atropine</strong> antagonizes these parasympathetic effects by competitive inhibition of acetylcholine at the muscarinic receptors.</p>\n<p><strong>Pralidoxime&nbsp;reactivates</strong> the <strong>acetylcholinesterase,&nbsp;</strong>which&nbsp;had been deactivated in organophosphate poisoning.&nbsp;Pralidoxime attaches to the anionic site of the enzyme that remains unoccupied. Then it<strong> reacts </strong>with the <strong>phosphorus atom</strong>&nbsp;of the organophosphorous compound which is attached to the esteric site to form a<strong> phospho-oxime complex. </strong>It then dissociates from the enzyme, regenerating the active enzyme.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2533",
      "difficulty": "medium"
    },
    {
      "text": "A sanitation worker presented with complaints of blurred vision, breathing difficulty and muscle weakness. He gave a history of spraying malathion this morning. You administer pralidoxime as an antidote. What is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Stimulation of ACh receptors"
        },
        {
          "id": 2,
          "text": "Inhibition of breakdown of ACh"
        },
        {
          "id": 3,
          "text": "Blockade of ACh receptors"
        },
        {
          "id": 4,
          "text": "Reactivation of AChE enzyme"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Pralidoxime<strong>&nbsp;reactivates cholinesterase,&nbsp;</strong>which would have been deactivated by phosphorylation caused by malathion.</p>\n<p><strong>Pralidoxime</strong> attaches to the anionic site of the enzyme that remains unoccupied. Then it<strong> reacts </strong>with the <strong>phosphorus atom</strong>&nbsp;of the organophosphorous compound which is attached to the esteric site to form a<strong> phospho-oxime complex. </strong>It then dissociates from the enzyme, regenerating the active enzyme.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2534",
      "difficulty": "easy"
    },
    {
      "text": "A young man is brought to the ER with a history of ingestion of carbamate-based insecticide. He is agitated with excessive sweating, lacrimation, and salivation. Which of the following should not be used for treatment?",
      "choices": [
        {
          "id": 1,
          "text": "Pralidoxime"
        },
        {
          "id": 2,
          "text": "Atropine"
        },
        {
          "id": 3,
          "text": "Magnesium sulfate purgative"
        },
        {
          "id": 4,
          "text": "Gastric lavage with activated charcoal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pralidoxime </strong>may be <strong>hazardous </strong>in oral poisoning with carbamate insecticides. It is not effective in <strong>carbamate</strong> <strong>anti-ChE poisoning</strong> as the <strong>anionic</strong> <strong>site</strong> required for attachment of oximes is<strong> occupied. </strong></p>\n<p>Oximes are usually contraindicated in carbamate poisoning, as they do not reactivate the enzyme. They also have anti-ChE activity of their own that may worsen the condition.  </p>\n<p>Option B: Atropine is the mainstay in the management of carbamate poisoning. </p>\n<p>Options C and D: Magnesium sulfate purgative and gastric lavage with activated charcoal can be tried in oral carbamate poisoning.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2535",
      "difficulty": "medium"
    },
    {
      "text": "A patient with diabetes and COPD developed post-operative urinary retention. Which of the following drugs can be used for short-term treatment of the condition?",
      "choices": [
        {
          "id": 1,
          "text": "Tamsulosin"
        },
        {
          "id": 2,
          "text": "Bethanechol"
        },
        {
          "id": 3,
          "text": "Terazosin"
        },
        {
          "id": 4,
          "text": "Methacoline"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Tamsulosin</strong> is the drug used to relieve the symptoms in cases of postoperative<strong> urinary retention </strong>in a patient with<strong> COPD.</strong></p>\n<p>It is also efficacious in the treatment of benign prostatic hyperplasia (BPH)&nbsp;with little effect on blood pressure.&nbsp;</p>\n<p>Option B:&nbsp;<strong>Bethanechol</strong> is the drug of choice to relieve the symptoms in cases of postoperative urinary retention. However, it&nbsp;can cause <strong>bronchoconstriction</strong> in patients with COPD. Hence tamsulosin is the best answer here.</p>\n<p>Option C:<strong>&nbsp;Terazosin</strong>&nbsp;is an &alpha;<sub>1</sub> receptor antagonist, used in the treatment of <strong>benign</strong> <strong>prostatic</strong> <strong>hyperplasia</strong> (BPH).&nbsp;</p>\n<p>Option D:&nbsp;<strong>Methacholine&nbsp;</strong>is a muscarinic agonist but acts specifically on <strong>bronchial</strong> <strong>smooth</strong> <strong>muscle</strong> causing its contraction. It is available as an inhalational agent and is used for the diagnosis of bronchial hyper-reactivity in patients who do not have clinically apparent asthma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0776",
      "difficulty": "medium"
    }
  ]
}